TOP STORIES
respiratory
Medicines

“Significant milestone” for inhaled budesonide benefit as early COVID-19 therapy


Inhaled budesonide can reduce the likelihood of requiring urgent medical care for a COVID-19 infection, and can shorten recovery time as well, according to two studies. Results of the STOIC trial are now fully peer reviewed, while the larger PRINCIPLE...

Inhaled budesonide can reduce the likelihood of requiring urgent medical care for a COVID-19 infection, and can shorten recovery time...

Read more